PTTG2 and Huntington disease: These findings were partially recapitulated in data from the HD tumor tissue cohort, where overexpression of KDELC1, RPL23A7, and DEGS1, but not PTTG2, was associated with worse overall survival (Fig. 2B–E, respectively).